Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antiviral drug
Pharma
Shionogi's antiviral comes up short in global COVID-19 trial
Shionogi's antiviral ensitrelvir missed the mark in a late-stage COVID-19 trial, putting a damper on U.S. approval prospects for the drug.
Fraiser Kansteiner
May 13, 2024 10:48am
Pfizer's Paxlovid access questioned ahead of WTO patent talks
Nov 21, 2022 11:41am
FDA swats away Gilead's hepatitis D treatment bulevirtide
Oct 28, 2022 9:52am
Gilead plots pivotal clinical trial for COVID oral antiviral
Oct 19, 2022 12:01am
Pfizer stops Paxlovid work in less vulnerable COVID patients
Jun 15, 2022 10:20am
Monkeypox outbreak won't be the next COVID: analysts
May 23, 2022 11:05am
